SNY - Sanofi ADR - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

SNY is currently covered by 8 analysts with an average price target of $94.38. This is a potential upside of $42.06 (80.39%) from yesterday's end of day stock price of $52.32.

Sanofi ADR's activity chart (see below) currently has 88 price targets and 68 ratings on display. The stock rating distribution of SNY is 63.16% BUY and 36.84% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 2.19% with an average time for these price targets to be met of 31.25 days.

Highest price target for SNY is $65, Lowest price target is $60, average price target is $70.21.

Most recent stock forecast was given by PETER VERDULT from CITI on 21-Mar-2025. First documented stock forecast 07-Mar-2017.

Currently out of the existing stock ratings of SNY, 12 are a BUY (63.16%), 7 are a HOLD (36.84%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$65

$12.68 (24.24%)

$133.21

1 months 6 days ago
(21-Mar-2025)

0/3 (0%)

$8.1 (14.24%)

Hold

4 months 24 days ago
(03-Dec-2024)

0/7 (0%)

$52.24 (114.06%)

Buy

$60

$7.68 (14.68%)

$60

9 months 1 days ago
(26-Jul-2024)

0/2 (0%)

$7.6 (14.50%)

Buy

$101.24

9 months 19 days ago
(08-Jul-2024)

0/2 (0%)

$56.38 (125.68%)

Buy

$64

9 months 25 days ago
(02-Jul-2024)

0/3 (0%)

$13.39 (26.46%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is SNY (Sanofi ADR) average time for price targets to be met?

On average it took 31.25 days on average for the stock forecasts to be realized with a an average price target met ratio 2.19

Which analyst has the current highest performing score on SNY (Sanofi ADR) with a proven track record?

LUISA HECTOR

Which analyst has the most public recommendations on SNY (Sanofi ADR)?

Luisa Hector works at BERENBERG and has 13 price targets and 8 ratings on SNY

Which analyst is the currently most bullish on SNY (Sanofi ADR)?

Keyur Parekh with highest potential upside - $89.36

Which analyst is the currently most reserved on SNY (Sanofi ADR)?

Geoffrey Porges with lowest potential downside - -$0

Sanofi ADR in the News

Press Release: Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis

Sanofi Winthrop Industrie Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis Results from the HERCULES phase 3 study showed delay in disability progression in people living with non-relapsing secondary progressive multiple sclerosis Tolebrutinib has the potential to be the first therapy to modulate immunologic drivers of chronic inflammation...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?